J. Ruiz-Ros

Effects of early use of captopril on haemodynamics and short-term ventricular remodelling in acute anterior myocardial infarction.

J. Galcerá-Tomás, P. Rodríguez-García, J. A. Nuño de la Rosa, 1993, European heart journal.

[Prognostic value of tumor necrosis factor-alpha in patients with ST-segment elevation acute myocardial infarction].

V. Vicente, A. Carrillo, F. García-Almagro, 2007, Revista espanola de cardiologia.

Role of endogenous opioids in syncope induced by head-up tilt test and its relationship with isoproterenol-dependent and isoproterenol-independent neurally-mediated syncope.

J. A. Nuño de la Rosa, F. Picó-Aracil, J. Ruiz-Ros, 1998, International journal of cardiology.

Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease

M. Garcia-Conesa, J. Espín, F. Tomás-Barberán, 2012, Cardiovascular Drugs and Therapy.

One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.

M. Garcia-Conesa, J. Espín, F. Tomás-Barberán, 2012, The American journal of cardiology.

Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.

M. Garcia-Conesa, J. Espín, F. Tomás-Barberán, 2012, Molecular nutrition & food research.

Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective

M. Garcia-Conesa, J. Espín, F. Tomás-Barberán, 2013, Annals of the New York Academy of Sciences.

"Reel Syndrome": a new form of Twiddler's syndrome?

J. Ruiz-Ros, M. Pérez-Paredes, F. Martínez-Corbalán, 1999, Circulation.

One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.

M. Garcia-Conesa, J. Espín, F. Tomás-Barberán, 2012, The American journal of cardiology.